62345-76-0 Usage
General Description
4-[2-(Dimethylamino)ethoxy]aniline 97 is a chemical compound that falls under the category of organic compounds, more specifically aniline and substituted anilines. This particular chemical has a molecular formula of C10H16N2O, implying it has 10 atoms of carbon, 16 of hydrogen, 2 of nitrogen, and 1 of oxygen. Being 97 in purity, it indicates the chemical is 97 percent pure, and the remaining 3 percent may likely be impurities or other minor substances. 4-[2-(DIMETHYLAMINO)ETHOXY]ANILINE 97 might possess multiple uses across various industries including the pharmaceutical, dye, rubber, or chemical sector, mostly due to its structural properties. However, like any organic chemical, it must be handled with care given potential risks associated with exposure or mishandling.
Check Digit Verification of cas no
The CAS Registry Mumber 62345-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,3,4 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 62345-76:
(7*6)+(6*2)+(5*3)+(4*4)+(3*5)+(2*7)+(1*6)=120
120 % 10 = 0
So 62345-76-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H16N2O/c1-12(2)7-8-13-10-5-3-9(11)4-6-10/h3-6H,7-8,11H2,1-2H3
62345-76-0Relevant articles and documents
COMPOUNDS TARGETING RNA-BINDING PROTEINS OR RNA-MODIFYING PROTEINS
-
, (2021/09/11)
The invention relates to a compound represented by Formula (I): or a pharmaceutically acceptable salt thereof, compositions comprising the same and methods of preparing and using the same. The variables are described herein.
WEE1 KINASE INHIBITORS AND METHODS OF TREATING CANCER USING THE SAME
-
, (2019/09/18)
A compound, or a pharmaceutically acceptable salts or prodrugs thereof, having the chemical structure (I) and methods of using these compounds to inhibit WEE1 kinase and treat cancer in a subject.
8,9-DIHYDROIMIDAZOLE[1,2-A]PYRIMIDO[5,4-E]PYRIMIDINE-5(6H)-KETONE COMPOUND
-
, (2019/10/10)
Disclosed are 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-one compounds, specifically represented by the Formula I: or a pharmaceutically acceptable salt or prodrug thereof, wherein A and R1-R7 are defined herein. Compounds having Formula I are Wee1 kinase inhibitors. Therefore, compounds of the disclosure may be used to treat diseases caused by abnormal Wee1 activity.
